The why
As many as 1 in 4 patients are living with long term conditions.
The cost of caring for those patients is increasing.
Digital health products (DHPs) are the answer but an ever-changing deployment landscape is holding innovators back.
If you want to develop DHPs that:
- enable patients managing complex conditions
- reach the market quickly
- tackle multiple indication areas
- scale globally
then you need to build them on a single platform.
Avegen’s HealthMachine™ platform is your solution.
The how
HealthMachine™ exists to achieve one thing – better outcomes for patients living with long term conditions.
HealthMachine™ deploys evidence-backed, user-validated, reusable modules to guarantee impact, while controlling costs.
HealthMachine™ stays ahead of the rapidly evolving security standards, privacy laws, mobile operating systems and the regulatory environment.
Use HealthMachine™ to design, build, deploy and maintain high quality, engaging, compliant DHPs that deliver results.
The what
Whether you are a pharmaceutical company, a healthcare provider, or a research institute – HealthMachine™ delivers you best in class DHPs safely, quickly and affordably, in any indication area, that serve the patient need and meet your core business KPIs.
See how by exploring our latest case studies or book a demo today!
More Case Studies
PAH
Problem Pulmonary arterial hypertension (PAH) is a rare, progressive, and life-threatening condition, for which there is no cure and therefore requires constant management by patients. Avegen was given the task to set-up a digital health solution that will support patient self-management and improve the patient-clinician connect. The goal of PAH management is to maintain low-risk […]
STOP
STOP (Successful Treatment Of Paranoia) is a patient-facing app that aims to reduce clinical symptoms of paranoia, in patients with mild to moderate paranoia. It is a self-administered 12-week programme using Cognitive Bias Modification for Interpretation therapy (CBM-I). Avegen in collaboration with King’s College London designed and set up STOP, the smartphone version of the therapy.
KLICK
Klick is a digitally-enabled HIV care pathway conceptualised by Chelsea and Westminster Hospital Foundation Trust (CWFT), Avegen and a major pharmaceutical company. Klick was designed and built by Avegen to integrate with and enhance CWFT’s outpatient service model, whilst delivering a positive experience for patients.